GENETIC ASPECTS OF ENDOMETRIAL CANCER
https://doi.org/10.17650/1994-4098-2009-0-1-2-72-75
Abstract
Whether endometrial cancer (EC) is associated with different allele variants of genes of the detoxification system of xenobiotics has been studied and analyzed. The study has been conducted on a sufficient number of patients (102 and 149 women in the study and control groups, respectively). The methods used have been quite adequate to solve the set task.
There are significant differences in the distribution of the frequency of genomes of the GSTM1 gene between patients with EC and the controls (χ2 =3.9, p = 005).
Homozygous carriers of GSTP1 gene mutation in EC patients are encountered more frequently in the control group (5.9 and 3.4%, respectively), which shows the increased probability of EC in women with this genotype; heterozygous carriers of mutation with Ile/Val genotype are also identified more frequently in EC patients (47.05 %) than those in the control group (33.5; p = 0.04); the odds ratio was 1.76, which suggests a high risk of EC.
About the Authors
V. A. Pushkarev
Department of Obstetrics and Gynecology and Department of Biology, Bashkir State Medical University, Republican Clinical Cancer Dispensary, Ministry of Health of the Republic of Bashkortostan
Russian Federation
Russian Federation
V. A. Kulavsky
Department of Obstetrics and Gynecology and Department of Biology, Bashkir State Medical University, Republican Clinical Cancer Dispensary, Ministry of Health of the Republic of Bashkortostan
Russian Federation
Russian Federation
T. V. Viktorova
Department of Obstetrics and Gynecology and Department of Biology, Bashkir State Medical University, Republican Clinical Cancer Dispensary, Ministry of Health of the Republic of Bashkortostan
Russian Federation
Russian Federation
G. M. Iskhakova
Department of Obstetrics and Gynecology and Department of Biology, Bashkir State Medical University, Republican Clinical Cancer Dispensary, Ministry of Health of the Republic of Bashkortostan
Russian Federation
Russian Federation
E. V. Kulavsky
Department of Obstetrics and Gynecology and Department of Biology, Bashkir State Medical University, Republican Clinical Cancer Dispensary, Ministry of Health of the Republic of Bashkortostan
Russian Federation
Russian Federation
References
1. Кулаков В.И., Тохиян А.А. Проблемы злокачественных новообразований репродуктивной системы в практике гинеколога. Сборник научных трудов Пленума Межведомственного научного совета по акушерству и гинекологии РАМН. Ижевск, 2000.
2. Чиссов В.И., Старинский В.В., Ременник Л.В. Злокачественные новообразования в Российской Федерации. М.: Медицина, 1997.
3. Bao H., Vepakomma M., Sarkar M. Benzo (a) pyren exposure induces CYP 1A1 activity and expression in human endometrial cells. J Steroid Biochem Mol Biol 2002;81:37—45.
4. Rebbeck T.R., Troxel A.B., Wang Y. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. J Nat Cancer Inst 2006;98:1311—20.
5. Адамян Л.В., Спицын В.А., Андреева Е.Н. Генетические аспекты гинекологических заболеваний. М.: Медицина, 1999.
6. Айламазян Э.К. Основные проблемы и прикладное значение экологической репродуктологии. Журн акуш и жен бол 2005;54:7—13.
7. Сивочалова О.В. Риск нарушений репродуктивного здоровья женщин при воздействии вредных факторов. Журн акуш и жен бол 2005;54;42—51.
8. Акуленко Л.В. О наследственном раке молочной железы, яичников и эндометрия (клиническая лекция). Пробл репрод 2004;10:20—7.
9. Анисимов В.Н. Старение и канцерогенез: роль генетических и канцерогенных факторов. Вопр онкол 2005;51:4—5.
10. Берштейн Л.М. Гормональный дисбаланс и его ассоциация с генетическими и генотоксическими параметрами при раке эндометрия: в поисках клинического эквивалента двух типов гормонального канцерогенеза. Вопр онкол 2005;51:7.
11. Бочков Н.П. Клиническая генетика. 2-е изд. М.: ГЭОТАР- Медиа, 2002.
12. Вихляева Е.М. Молекулярно- генетические детерминаторы опухолевого роста и обоснование современной стратегии ведения больных лейомиомой матки. Вопр онкол 2001;47:200—4.
13. Новик А.А., Камилова Т.А., Цыган В.Н. Генетика в клинической медицине. СПб.: ВМедА, 2001.
14. Шарафисламова Э.Ф., Викторова Т.В., Хуснутдинова Э.К. Полиморфизм генов глутатион S- трансфераз М1 и Р1 у больных эндометриозом из Башкортостана. Мед генет 2003;2:136—40.
15. Doherty J.A., Weiss N.S., Freeman R.J. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomark Prev 2005;14(2):357—66.
16. Park S., Kang D., Noh D. et al. Reproductive factors, glutathione S- transferase M1 and T1 genetic polymor- phism and brest cancer risk. Breast Cancer Res and Treat 2003;78(1): 89—96.
Review
For citations:
Pushkarev V.A., Kulavsky V.A., Viktorova T.V., Iskhakova G.M., Kulavsky E.V. GENETIC ASPECTS OF ENDOMETRIAL CANCER. Tumors of female reproductive system. 2009;(1-2):72-75. (In Russ.) https://doi.org/10.17650/1994-4098-2009-0-1-2-72-75
Views:
645
Email this article 